Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Borea Therapeutics logo — Borea Therapeutics develops next-generation gene therapy vec...

Borea Therapeutics

Borea Therapeutics develops next-generation gene therapy vectors using a knowledge-based capsid design platform

Founded 2021 5 employees Seed Biotechnology, Health Care +1

General Information

Company Name Borea Therapeutics
Founded Year 2021
Employees 5
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when Borea Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Borea Therapeutics

Borea Therapeutics is a pioneering biotechnology startup that specializes in developing next-generation gene therapy vectors through an innovative knowledge-based capsid design platform. Founded in 2021, the company operates within the industries of Biotechnology, Health Care, and Health and Wellness. Borea Therapeutics recently secured a significant milestone with a Seed Round investment on 29 June 2021, with Sofinnova Partners as the key investor. This strategic funding injection is expected to propel the company's cutting-edge research and development initiatives, positioning it as a promising player in the rapidly evolving landscape of gene therapy innovation.

Taxonomy: gene therapy, vectors, capsid design platform, targeted therapy, translational medicine, precision medicine, biomedical engineering

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
29 Jun 2021

Borea Therapeutics Alternatives & Competitors

Borea Therapeutics vs
Alpstein-Clinic, Gais - Switzerland
Alpstein-Clinic, Gais - Switzerland Switzerland

Gesundheitszentrum für Integrative Biologisch Medizin und Zahnmedizin

16 employees
Health Care
Borea Therapeutics vs
CTRF health space
CTRF health space Spain

Regenerate your health through awareness.

5 employees
Health Care
Borea Therapeutics vs
PrimeMED
PrimeMED United States

Specializing in the care of acute injuries and primary care.

21 employees
Care Economy, Health Care

FAQ About Borea Therapeutics

Borea Therapeutics develops next-generation gene therapy vectors using a knowledge-based capsid design platform
Borea Therapeutics was founded in 2021.
Borea Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Borea Therapeutics has approximately 5 employees.
Borea Therapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Borea Therapeutics include Alpstein-Clinic, Gais - Switzerland, CTRF health space, PrimeMED, Goodlife Physical Medicine, New York Center for Innovative Medicine (NYCIM). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Borea Therapeutics and Alpstein-Clinic, Gais - Switzerland are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Borea Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy